May 30, 2024
Answer ALS Hosts Inaugural IgNight ALS in Washington, D.C.
WASHINGTON, D.C. [May 30, 2024]: Answer ALS hosted the inaugural IgNight ALS, a program that convened leaders from scien...
March 7, 2024
ALS Therapy Development Institute, Answer ALS, and Microsoft Announce Groundbreaking Data Sharing Collaboration
The ALS Therapy Development Institute (ALS TDI), Answer ALS, and Microsoft are pleased to announce a collaboration that ...
January 30, 2024
ANSWER ALS ANNOUNCES DR. JEFFREY KELLER TO LEADERSHIP OF THEIR UNPRECEDENTED OPEN ACCESS ALS DATA REPOSITORY
Dr. Jeffrey Keller to Co-Lead Answer ALS’ Unprecedented Open Access ALS Data Repository. Appointment to Answer ALS...
December 19, 2023
2023 Year In Review
10 Years of Commitments Met. Ten years ago, Answer ALS didn’t have a name, but the plan was developed to empower r...
March 2, 2023
The Answer ALS 2022 4th Quarter News & Updates
Our 2022 4th quarter newsletter is available here. There has been a lot to celebrate, but there is so much more work to ...
March 2, 2023
Large-scale differentiation of iPSC-derived motor neurons from ALS and control subjects
ALS Motor Neurons Differ by Sex, Study Finds. A new Cedars-Sinai study in collaboration with the University of Californi...
Data & Technology
Multi-Omnics Analysis
IPS Cells & Motor Neurons
Clinic & enrollment